CRONOS GROUP INC. Impairment of Long-Lived Assets Held-for-use
CRONOS GROUP INC. (CRON) reported Impairment of Long-Lived Assets Held-for-use of $36.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ImpairmentOfLongLivedAssetsHeldForUse · last filed 2026-02-26
- CRONOS GROUP INC. impairment of long-lived assets held-for-use for the quarter ending 2025-12-31 was $0.00.
- CRONOS GROUP INC. impairment of long-lived assets held-for-use for the quarter ending 2025-09-30 was $36.00K, a 99.75% decline year-over-year.
- CRONOS GROUP INC. impairment of long-lived assets held-for-use for the quarter ending 2025-06-30 was $0.00.
- CRONOS GROUP INC. impairment of long-lived assets held-for-use for the quarter ending 2025-03-31 was $0.00, a 100.00% decline year-over-year.
- CRONOS GROUP INC. impairment of long-lived assets held-for-use for fiscal 2025 was $36.00K, a 99.78% decline from fiscal 2024.
- CRONOS GROUP INC. impairment of long-lived assets held-for-use for fiscal 2024 was $16.35M, a 385.74% increase from fiscal 2023.
- CRONOS GROUP INC. impairment of long-lived assets held-for-use for fiscal 2023 was $3.37M, a 3.64% decline from fiscal 2022.
- CRONOS GROUP INC. impairment of long-lived assets held-for-use for fiscal 2022 was $3.49M, a 97.24% decline from fiscal 2021.
| Period end | Impairment of Long-Lived Assets Held-for-use 3 month | Impairment of Long-Lived Assets Held-for-use 6 month | Impairment of Long-Lived Assets Held-for-use 9 month | Impairment of Long-Lived Assets Held-for-use 12 month | Impairment of Long-Lived Assets Held-for-use 12 month as first filed |
|---|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $36.00K derived: sum of 2 quarters · filed 2026-02-26 | $36.00K derived: sum of 3 quarters · filed 2026-02-26 | $36.00K 10-K · filed 2026-02-26 | |
| 2025-09-30 | $36.00K 10-Q · filed 2025-11-06 | $36.00K derived: sum of 2 quarters · filed 2025-11-06 | $36.00K 10-Q · filed 2025-11-06 | $36.00K derived: sum of 4 quarters · filed 2026-02-26 | |
| 2025-06-30 | $0.00 10-Q · filed 2025-08-07 | $0.00 10-Q · filed 2025-08-07 | $0.00 derived: sum of 3 quarters · filed 2026-02-26 | $14.38M derived: sum of 4 quarters · filed 2026-02-26 | |
| 2025-03-31 | $0.00 10-Q · filed 2025-05-08 | $0.00 derived: sum of 2 quarters · filed 2026-02-26 | $14.38M derived: sum of 3 quarters · filed 2026-02-26 | $14.38M derived: sum of 4 quarters · filed 2026-02-26 | |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $14.38M derived: sum of 2 quarters · filed 2026-02-26 | $14.38M derived: sum of 3 quarters · filed 2026-02-26 | $16.35M 10-K · filed 2026-02-26 | |
| 2024-09-30 | $14.38M 10-Q · filed 2025-11-06 | $14.38M derived: sum of 2 quarters · filed 2025-11-06 | $16.35M 10-Q · filed 2025-11-06 | $19.72M derived: sum of 4 quarters · filed 2026-02-26 | |
| 2024-06-30 | $0.00 10-Q · filed 2025-08-07 | $1.97M 10-Q · filed 2025-08-07 | $5.34M derived: sum of 3 quarters · filed 2026-02-26 | $5.34M derived: sum of 4 quarters · filed 2026-02-26 | |
| 2024-03-31 | $1.97M 10-Q · filed 2025-05-08 | $5.34M derived: sum of 2 quarters · filed 2026-02-26 | $5.34M derived: sum of 3 quarters · filed 2026-02-26 | $5.34M derived: sum of 4 quarters · filed 2026-02-26 | |
| 2023-12-31 | $3.37M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $3.37M derived: sum of 2 quarters · filed 2026-02-26 | $3.37M derived: sum of 3 quarters · filed 2026-02-26 | $3.37M 10-K · filed 2026-02-26 | |
| 2023-09-30 | $0.00 10-Q · filed 2024-11-12 | $0.00 derived: sum of 2 quarters · filed 2024-11-12 | $0.00 10-Q · filed 2024-11-12 | $0.00 derived: sum of 4 quarters · filed 2025-02-27 | |
| 2023-06-30 | $0.00 10-Q · filed 2024-08-08 | $0.00 10-Q · filed 2024-08-08 | $0.00 derived: sum of 3 quarters · filed 2025-02-27 | $0.00 derived: sum of 4 quarters · filed 2025-02-27 | |
| 2023-03-31 | $0.00 10-Q · filed 2024-05-09 | $0.00 derived: sum of 2 quarters · filed 2025-02-27 | $0.00 derived: sum of 3 quarters · filed 2025-02-27 | $0.00 derived: sum of 4 quarters · filed 2025-02-27 | |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $0.00 derived: sum of 2 quarters · filed 2025-02-27 | $0.00 derived: sum of 3 quarters · filed 2025-02-27 | $3.49M 10-K · filed 2025-02-27 | |
| 2022-09-30 | $0.00 10-Q · filed 2023-11-08 | $0.00 derived: sum of 2 quarters · filed 2023-11-08 | $3.49M 10-Q · filed 2023-11-08 | $125.16M derived: sum of 4 quarters · filed 2024-02-29 | |
| 2022-06-30 | $0.00 10-Q · filed 2023-08-08 | $3.49M 10-Q · filed 2023-08-08 | $125.16M derived: sum of 3 quarters · filed 2024-02-29 | $126.94M derived: sum of 4 quarters · filed 2024-02-29 | |
| 2022-03-31 | $3.49M 10-Q · filed 2023-05-09 | $125.16M derived: sum of 2 quarters · filed 2024-02-29 | $126.94M derived: sum of 3 quarters · filed 2024-02-29 | $128.16M derived: sum of 4 quarters · filed 2024-02-29 | |
| 2021-12-31 | $121.67M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $123.45M derived: sum of 2 quarters · filed 2024-02-29 | $124.66M derived: sum of 3 quarters · filed 2024-02-29 | $126.41M 10-K · filed 2024-02-29 | $127.62M 10-K · filed 2022-03-01 |
| 2021-09-30 | $1.78M 10-Q · filed 2022-11-07 | $3.00M derived: sum of 2 quarters · filed 2022-11-07 | $4.74M 10-Q · filed 2022-11-07 | $4.74M derived: sum of 4 quarters · filed 2023-02-28 | |
| 2021-06-30 | $1.21M 10-Q · filed 2022-08-09 | $2.96M 10-Q · filed 2022-08-09 | $2.96M derived: sum of 3 quarters · filed 2023-02-28 | $2.96M derived: sum of 4 quarters · filed 2023-02-28 | |
| 2021-03-31 | $1.74M 10-Q · filed 2022-05-10 | $1.74M derived: sum of 2 quarters · filed 2023-02-28 | $1.74M derived: sum of 3 quarters · filed 2023-02-28 | ||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $0.00 derived: sum of 2 quarters · filed 2023-02-28 | $0.00 10-K · filed 2023-02-28 | ||
| 2020-09-30 | $0.00 10-Q · filed 2022-02-18 | $0.00 10-Q · filed 2022-02-18 | |||
| 2019-12-31 | $0.00 10-K · filed 2022-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |